Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).

Zinman, Bernard; Philis-Tsimikas, Athena; Cariou, Bertrand; Handelsman, Yehuda; W Rodbard, Helena; Johansen, Thue; Endahl, Lars; Mathieu, Chantal; (BEGIN Once Long) Trial Investigators, NN1250-3579

doi:10.2337/dc12-1205

Public

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).

Shared by NobleBlocks on Dec 1, 2012 • 12:00 AM UTC

Authors:

Bernard Zinman

Athena Philis-Tsimikas

Bertrand Cariou

Abstract

OBJECTIVE: To compare ultra-long-acting insulin degludec with glargine for efficacy and safety in insulin-naive patients with type 2 diabetes inadequately controlled with oral antidiabetic drugs (OADs). RESEARCH DESIGN AND METHODS: In this 1-year, parallel-group, randomized, open-label, treat-to-tar...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!